or Try an Advanced Search...

    Technical Analysis for SHPH - Shuttle Pharmaceuticals Holdings, Inc.

    Grade Last Price % Change Price Change
    F 0.90 0.79% 0.01
    SHPH closed up 0.79 percent on Wednesday, November 20, 2024, on 3 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SHPH trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 0.79%
    New 52 Week Low Weakness 0.79%
    Wide Bands Range Expansion 0.79%
    Down 3 Days in a Row Weakness 0.79%
    Older End-of-Day Signals for SHPH ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    Possible Inside Day about 18 hours ago
    Up 3% about 22 hours ago
    Up 2% about 22 hours ago
    Up 1% about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SHPH Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Cancer Radiation Radiation Therapy Sarcoma Brain Tumor Soft Tissue Sarcoma Liver Cancer

    Is SHPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Shuttle Pharma Provides Third Quarter 2024 Corporate Update
    Oct 30 Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
    Oct 30 Shuttle Pharmaceuticals dips 6%, prices $4.5M share offering
    Oct 30 Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
    Oct 29 Shuttle Pharma Pays Off Senior Secured Convertible Note
    Oct 29 Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
    Oct 29 Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
    Oct 28 Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
    Oct 28 Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024
    Sep 20 Shuttle Pharmaceuticals files for offering common stock, warrants
    See more SHPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.9464
    52 Week Low 0.8338
    Average Volume 1,371,049
    200-Day Moving Average 2.66
    50-Day Moving Average 1.31
    20-Day Moving Average 1.29
    10-Day Moving Average 1.05
    Average True Range 0.15
    RSI (14) 32.43
    ADX 16.15
    +DI 22.81
    -DI 29.58
    Chandelier Exit (Long, 3 ATRs) 1.79
    Chandelier Exit (Short, 3 ATRs) 1.29
    Upper Bollinger Bands 1.88
    Lower Bollinger Band 0.69
    Percent B (%b) 0.17
    BandWidth 92.65
    MACD Line -0.13
    MACD Signal Line -0.08
    MACD Histogram -0.0472
    Fundamentals Value
    Market Cap 14.37 Million
    Num Shares 16 Million
    EPS -0.40
    Price-to-Earnings (P/E) Ratio -2.25
    Price-to-Sales 0.00
    Price-to-Book 1.08
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.98
    Resistance 3 (R3) 0.98 0.95 0.97
    Resistance 2 (R2) 0.95 0.93 0.95 0.97
    Resistance 1 (R1) 0.92 0.91 0.94 0.93 0.96
    Pivot Point 0.89 0.89 0.90 0.89 0.89
    Support 1 (S1) 0.87 0.87 0.88 0.87 0.84
    Support 2 (S2) 0.84 0.86 0.84 0.83
    Support 3 (S3) 0.81 0.84 0.83
    Support 4 (S4) 0.81